Source: ERJ Open Res, 8 (1) 00443-2021; 10.1183/23120541.00443-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Paola Faverio, Alessia Fumagalli, Sara Conti, Fabiana Madotto, Francesco Bini, Sergio Harari, Michele Mondoni, Tiberio Oggionni, Emanuela Barisione, Paolo Ceruti, Maria Chiara Papetti, Bruno Dino Bodini, Antonella Caminati, Angela Valentino, Stefano Centanni, Donatella Noè, Matteo Della Zoppa, Silvia Crotti, Marco Grosso, Samir Giuseppe Sukkar, Denise Modina, Marco Andreoli, Roberta Nicali, Giulia Suigo, Federica De Giacomi, Sara Busnelli, Elena Cattaneo, Lorenzo Giovanni Mantovani, Giancarlo Cesana, Alberto Pesci, Fabrizio Luppi. Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study. ERJ Open Res, 8 (1) 00443-2021; 10.1183/23120541.00443-2021

Member's Comments

No comment yet.

Related content which might interest you: Home oxygen saturation monitoring and quality of life in patients with idiopathic pulmonary fibrosis: A prospective multicenter trial Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019 Year: 2020 Comparison of Interferon gamma-1b (IFN-γ)and colcicine in the treatment of Idiopathic pulmonary fibrosis: preliminary results of a prospective, multicenter randomised study Source: Eur Respir J 2002; 20: Suppl. 38, 599s Year: 2002 Concomitant corticosteroid with anti-fibrotic therapy for idiopathic pulmonary fibrosis: a prospective multicenter study Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study Source: Eur Respir J, 53 (3) 1801587; 10.1183/13993003.01587-2018 Year: 2019 Nutritional assessment in patients with idiopathic pulmonary fibrosis: the NUTRIPF study Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Prevalence of cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Clinical pattern of idiopathic pulmonary fibrosis in Iran: A retrospective study Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Prevalence and mechanism of pulmonary hypertension in sickle cell disease: a prospective multicentre french study Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension Year: 2009 A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study Source: Eur Respir J, 53 (2) 1801186; 10.1183/13993003.01186-2018 Year: 2019 Quantitative analysis of lung sounds for monitoring idiopathic pulmonary fibrosis: a prospective pilot study Source: Eur Respir J, 53 (3) 1802093; 10.1183/13993003.02093-2018 Year: 2019 Exploring barriers to Pirfenidone adherence in patients with idiopathic pulmonary fibrosis: a prospective study Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 Benefits of pulmonary rehabilitation in COVID-19 – a prospective observational cohort study Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19 Year: 2021 Prognostic factors of pulmonary embolism: results of a prospective multicenter study Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease Year: 2008 Azithromycin for the treatment of cough in idiopathic pulmonary fibrosis: A randomized controlled cross-over pilot trial. Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020 Dronabinol in COPD-induced pulmonary cachexia: an observational study Source: Eur Respir J 2005; 26: Suppl. 49, 720s Year: 2005 Effectiveness of non-invasive ventilation in stable chronic obstructive pulmonary disease with nocturnal desaturation: Prospective open-label randomized parallel-group study Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes Year: 2013 Prospective observational study in patients with obstructive lung disease: NOVELTY design Source: ERJ Open Res, 5 (1) 00036-2018; 10.1183/23120541.00036-2018 Year: 2019